Showing results (141-150 of 288) with videos related to

Sort By:
Pageof 29
ERJ Open Research|December 17, 2024
Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristicsMichael E Wechsler, Linda Rogers, G Walter Canonica, et al.
ERJ Open Research|January 10, 2024
Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristicsDavid R W Jayne, Benjamin Terrier, Bernhard Hellmich, et al.
ACR Open Rheumatology|June 13, 2023
Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic PhenotypeBenjamin Terrier, David R W Jayne, Bernhard Hellmich, et al.
The Journal of Allergy and Clinical Immunology|October 1, 2025
Asthma remission in the context of other immune-mediated diseasesJosef Smolen, Bruce E Sands, Daniel J Jackson, et al.
ERJ Open Research|March 9, 2023
Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial designLucia De Prado Gomez, Ian Pavord, William Busse, et al.
JAMA|October 28, 2015
Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical TrialMichael E Wechsler, Barbara P Yawn, Anne L Fuhlbrigge, et al.
Springerplus|December 9, 2014
LTC4 synthase polymorphism modifies efficacy of botanical seed oil combination in asthmaShamsah Kazani, Jonathan P Arm, Joshua Boyce, et al.
The Lancet. Respiratory Medicine|July 13, 2021
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trialSarah Diver, Latifa Khalfaoui, Claire Emson, et al.
Allergy|June 23, 2025
Burden of Oral Corticosteroid Use in Severe Asthma: Challenges and OpportunitiesG Walter Canonica, Celeste Porsbjerg, David B Price, et al.
The Journal of Allergy and Clinical Immunology|July 20, 2010
Refining the definition of hypereosinophilic syndromeHans-Uwe Simon, Marc E Rothenberg, Bruce S Bochner, et al.
Pageof 29